Hiroki Yamanaka, Eiichi Sawaragi, Takashi Nakano, Yasuhiro Katayama, Tatsuya Ito, Harue Tada, Yu Hidaka, Satoshi Morita, Chihiro Funakoshi, Akemi Kinoshita, et al. A high-hydrostatic pressure device for nevus tissue inactivation and dermal regeneration for reconstructing skin defects after giant congenital melanocytic nevus excision: a clinical trial. Regenerative Therapy. 2023. 24. 167-173
Naoshi Sugimoto, Junya Kanda, Sou Nakamura, Toshiyuki Kitano, Masakatsu Hishizawa, Tadakazu Kondo, Shin Shimizu, Akiko Shigemasa, Hideyo Hirai, Yasuyuki Arai, et al. iPLAT1: The first-in-human clinical trial of iPSC-derived platelets as a phase 1 autologous transfusion study. Blood. 2022. 140. 22. 2398-2402
Shusuke Akamatsu, Naoki Terada, Ryo Takata, Hidefumi Kinoshita, Kimihiro Shimatani, Yukihide Momozawa, Michio Yamamoto, Harue Tada, Naoki Kawamorita, Shintaro Narita, et al. Clinical Utility of Germline Genetic Testing in Japanese Men Undergoing Prostate Biopsy. JNCI cancer spectrum. 2022. 6. 1
Yukiko Mori, Osamu Kikuchi, Takahiro Horimatsu, Hiroki Hara, Shuichi Hironaka, Takashi Kojima, Ken Kato, Takahiro Tsushima, Ryu Ishihara, Kumi Mukai, et al. Multicenter phase II study of trifluridine/tipiracil for esophageal squamous carcinoma refractory/intolerant to 5-fluorouracil, platinum compounds, and taxanes: the ECTAS study. Esophagus : official journal of the Japan Esophageal Society. 2022. 19. 3. 444-451
Takashi Nomura, Eriko Sumi, Gyohei Egawa, Saeko Nakajima, Eiko Toichi, Nana Inoue, Mami Shibuya, Natsuko Okamoto, Tsuyoshi Mitsuishi, Ryuji Uozumi, et al. Safety and Efficacy of FIT039 for Verruca Vulgaris: A Placebo-Controlled, Phase I/II Randomized Controlled Trial. JID innovations : skin science from molecules to population health. 2021. 1. 3. 100026-100026
